Published in J Gen Virol on February 01, 1995
Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol (2003) 3.92
Isolation and molecular characterization of genotype 1 Japanese encephalitis virus, SX09S-01, from pigs in China. Virol J (2011) 1.03
Genomic analysis of a newly isolated of Japanese encephalitis virus strain, CQ11-66, from a pediatric patient in China. Virol J (2013) 0.91
Age-related susceptibility to Japanese encephalitis virus in domestic ducklings and chicks. Am J Trop Med Hyg (2014) 0.82
Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain. BMC Infect Dis (2013) 0.80
Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay. J Clin Microbiol (2001) 0.79
A comprehensive analysis of predicted HLA binding peptides of JE viral proteins specific to north Indian isolates. Bioinformation (2014) 0.75
Inference of Japanese encephalitis virus ecological and evolutionary dynamics from passive and active virus surveillance. Virus Evol (2016) 0.75
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol (2001) 2.59
Phylogeny of the Simbu serogroup of the genus Bunyavirus. J Gen Virol (2001) 2.30
Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol (1986) 1.83
Genetic variation in the 3' non-coding region of dengue viruses. Virology (2001) 1.71
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa. Virology (1996) 1.53
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J Virol (2001) 1.47
Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J Gen Virol (1995) 1.44
Rapid identification of flaviviruses based on conserved NS5 gene sequences. J Virol Methods (1993) 1.30
Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology (1998) 1.30
Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol (1995) 1.29
Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology (1998) 1.28
Improved sweat test method for the diagnosis of cystic fibrosis. Arch Dis Child (1984) 1.20
Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Res (2001) 1.20
Molecular epidemiological studies of veterinary arboviral encephalitides. Vet J (1999) 1.15
Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. J Gen Virol (1995) 1.13
Antibody-mediated early death in vivo after infection with yellow fever virus. J Gen Virol (1986) 1.13
Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol (1994) 1.11
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosom Med (2001) 1.08
West Nile virus strains differ in mouse neurovirulence and binding to mouse or human brain membrane receptor preparations. Ann N Y Acad Sci (2001) 1.07
Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine (2001) 1.07
Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology (1997) 1.07
Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. J Virol (2000) 1.06
Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Virology (1999) 1.03
Prospects for a virus non-structural protein as a subunit vaccine. Vaccine (1988) 1.03
Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol (1996) 1.01
Nucleotide sequence of the NS5 gene of Banzi virus: comparison with other flaviviruses. J Gen Virol (1995) 1.00
Comparison of neurovirulence of different strains of yellow fever virus in mice. J Gen Virol (1986) 1.00
Nucleotide sequencing and serological evidence that the recently recognized deer tick virus is a genotype of Powassan virus. Virus Res (2001) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation (2000) 0.99
Nucleotide sequence of the envelope protein of a Turkish isolate of tick-borne encephalitis (TBE) virus is distinct from other viruses of the TBE virus complex. J Gen Virol (1993) 0.98
Epitope mapping of the gp53 envelope protein of bovine viral diarrhea virus. Virology (1992) 0.97
Nucleotide sequence and deduced amino acid sequence of the medium RNA segment of Oropouche, a Simbu serogroup virus: comparison with the middle RNA of Bunyamwera and California serogroup viruses. Virus Res (2001) 0.95
Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry. J Virol Methods (1998) 0.95
Genetic variation among strains of wild-type yellow fever virus from Senegal. J Gen Virol (1997) 0.94
Propagation of human candidate calicivirus in cell culture. J Gen Virol (1984) 0.93
Amino acid substitution(s) in the stem-anchor region of langat virus envelope protein attenuates mouse neurovirulence. Virology (2001) 0.93
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J Gen Virol (1988) 0.93
In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virus. J Gen Virol (1991) 0.92
Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations. Virus Res (1998) 0.89
A rapid method for the inactivation of virus infectivity prior to assay for interferons. J Virol Methods (1984) 0.88
Defective interfering particles of Semliki Forest virus are smaller than particles of standard virus. J Gen Virol (1984) 0.87
Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area. Vaccine (1992) 0.87
Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J Gen Virol (1997) 0.87
Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus. J Gen Virol (1998) 0.84
Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system. J Gen Virol (1986) 0.82
Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles. J Gen Virol (1986) 0.82
Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. J Virol (1992) 0.82
Assay of defective-interfering semliki forest virus by the inhibition of synthesis of virus-specified RNAs. J Gen Virol (1981) 0.81
Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus. J Gen Virol (1984) 0.80
Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus. J Infect Dis (1984) 0.80
Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay. J Clin Microbiol (2001) 0.79
Nucleotide sequence of the envelope protein gene of the tick-borne flavivirus, Kumlinge A52. Virus Genes (1993) 0.79
Propagation and preliminary characterization of a chicken candidate calicivirus. J Gen Virol (1985) 0.79
The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture. Virus Res (2000) 0.78
Variation in homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus. J Gen Virol (1984) 0.78
Local and systemic antibody class responses to an infectious laryngotracheitis virus vaccine strain. Avian Pathol (1992) 0.77
Defective interfering Semliki Forest virus populations are biologically and physically heterogeneous. J Gen Virol (1984) 0.77
IgM responses in chicken serum to live and inactivated infectious bronchitis virus vaccines. Avian Dis (1991) 0.76
Attenuation of virulence of flaviviruses following passage in HeLa cells. J Gen Virol (1990) 0.76
Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication. J Gen Virol (1984) 0.76
Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses. Vaccine (1993) 0.76
Langat virus M protein is structurally homologous to prM. J Virol (2001) 0.75
Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies. Biologicals (1992) 0.75
Primer extension dideoxy chain termination nucleotide sequencing of partially purified RNA virus genomes: a technique for investigating low titre viruses with extensive genome secondary structure. J Virol Methods (1990) 0.75
Immunogenicity of experimental live attenuated Japanese encephalitis vaccine viruses and comparison with wild-type strains using monoclonal and polyclonal antibodies. Vaccine (1992) 0.75
Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus. Vaccine (1994) 0.75
Yellow fever 17DD vaccine virus is temperature sensitive when grown in mosquito C6-36 cells. Vaccine (1992) 0.75
Rapid detection of viruses of the tick-borne encephalitis virus complex by RT-PCR of viral RNA. J Virol Methods (1993) 0.75
Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report. Arch Virol (1984) 0.75
Differential effects of defective interfering Semliki Forest virus on cellular and virus polypeptide synthesis. Virology (1985) 0.75
Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice. Vaccine (1990) 0.75
Neurochemical changes in brains of mice infected with Pichinde virus. Med Microbiol Immunol (1986) 0.75